OmniAb put its OmniUltra platform at the center of discussion at the San Diego Targeted Radiopharmaceuticals Summit, highlighting its use in radioligand therapy

OmniAb put its OmniUltra platform at the center of discussion at the San Diego Targeted Radiopharmaceuticals Summit, highlighting its use in radioligand therapy. Strong engagement around the presentation underscored interest in new peptide-based discovery tools.